Advocacy Foundations Bridging Gap Between Research & Drug Development
This article was originally published in The Pink Sheet Daily
Observers say that research foundations are moving away from funding pure science to behaving more like venture capitalists. Groups like the Cystic Fibrosis Foundation are awarding grants for Phase I and II clinical trials as well as operating nonprofit drug development firms.
You may also be interested in...
Gilead Sciences will price its cystic fibrosis drug Cayston at an 8 percent premium to its competitor, Novartis' TOBI (tobramycin)
"Personalized" hair-care firm Profound Beauty is growing its presence online to attract new customers while preserving its status as a prestige brand